WHO ICTRP trial
Exploring the Benefits of Xuezhikang in Achieving Lower LDL-C Levels for Primary…
ChiCTR2500101995 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500101995 |
|---|---|
| Public title | Exploring the Benefits of Xuezhikang in Achieving Lower LDL-C Levels for Primary Prevention in High-Risk ASCVD Populations and Its Impact on the Development of Generalized Atherosclerosis |
| Scientific title | Exploring the Benefits of Xuezhikang in Achieving Lower LDL-C Levels for Primary Prevention in High-Risk ASCVD Populations and Its Impact on the Development of Generalized Atherosclerosis |
| Primary sponsor | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | atherosclerosis |
| Interventions | control group:Therapeutic lifestyle changes;treatment group:Therapeutic lifestyle changes + Xuezhikang |
| Registration date | May 7, 2025 |
| Target size | control group:50;treatment group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: